OM - Outset Medical Inc

OM - Outset Medical Inc

https://www.outsetmedical.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Tempus ( TEM ) Stock Jumps 13.6%: Will It Continue to Soar?

Zacks Commentary • 3 days, 3 hours ago

Tempus (TEM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Outset Medical ( NASDAQ:OM )

Benzinga • 1 week, 3 days ago • score: 0.02

NEW YORK, Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc.

Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference - Outset Medical ( NASDAQ:OM )

Benzinga • 3 weeks, 4 days ago • score: 0.33

SAN JOSE, Calif., Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Outset Medical, Inc. OM ( "Outset" ) , a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan Stanley Global ...

Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference

GlobeNewswire • 3 weeks, 4 days ago

SAN JOSE, Calif., Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Outset Medical, Inc. ( Nasdaq: OM ) ( "Outset" ) , a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan ...

After Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical ( OM )

Zacks Commentary • 1 month ago • score: 0.22

Outset Medical (OM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Outset Medical, Inc. ( OM ) Reports Q2 Loss, Beats Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.07

Outset Medical (OM) delivered earnings and revenue surprises of +52.27% and +5.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. The company is headquartered in San Jose, California.

52W High

$25.35

52W Low

$5.85

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

2.13

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.24

EV/Revenue (<3 favorable)

1.40

P/S (TTM) (<3 favorable)

2.09

P/B (<3 favorable)

1.65

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

2.70%

Institutions (25–75% balanced)

103.26%

Shares Outstanding

17,766,200

Float

11,274,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

119,304,000

Gross Profit (TTM)

43,866,000

EPS (TTM)

-18.75

Profit Margin (>10% good)

-0.82%

Operating Margin (TTM) (higher better)

-0.54%

ROE (TTM) (>15% strong)

-0.88%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.15

Momentum

Bearish momentum

Value

-0.3741

Previous

-0.3837

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025